Founded in 2006, EUSA Pharma is a specialty pharmaceutical company that focuses on oncology and oncology supportive care, as well as pain control and critical care products. The company’s products include Caphosol for the treatment of oral mucositis; ProstaScint for imaging the extent and spread of prostate cancer; Quadramet for the treatment of pain in patients and a variety of others. The company is based in Langhorne, Pennsylvania. EUSA Pharma operates as a subsidiary of Essex Bidco Ltd.